Date: 12 October 2018
Researchers are being asked to investigate the effectiveness of cannabis-based products for medicinal use under a new NIHR themed research call.
Investigators can submit their research proposals to look at the use of products for difficult-to-treat epilepsy or other disorders unresponsive to existing treatments.
Applications should meet all the professional and legal requirements within which cannabis-based products for medicinal use may be prescribed and lead to robust clinical evidence that will inform practice.
The invitation for applications comes following a review of the Chief Medical Officer, Professor Dame Sally Davies, to the UK Government. The review considered a range of evidence from a number of international sources and recommended that the whole class of cannabis based medicinal products be moved out of Schedule 1 of the Misuse of Drugs Regulations.
For further details about this research call visit the themed calls page.
You may also be interested in